| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.087 | 0.05 |